Screening for Bladder Cancer

Final Recommendation From the U.S. Preventive Services Task Force: Screening for Bladder Cancer in Asymptomatic Adults

In an update to its 2004 recommendation, the U.S. Preventive Services Task Force (USPSTF) concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for bladder cancer in asymptomatic adults. This is an I statement. Previously, the USPSTF concluded that the harms outweighed the benefits of screening for bladder cancer. The update focused on the benefits and harms of screening among people without symptoms, the accuracy of screening tests done in primary care settings, and the benefits and harms of treatment. The updated evidence review did not find any new high quality evidence to adequately determine the balance of benefits and harms of screening for bladder cancer. However, bladder cancer is a common cancer and can cause considerable health problems including death. Therefore, the Task Force determined that the evidence was insufficient to provide a recommendation for or against bladder cancer screening. The USPSTF emphasizes the need for additional research in this area.

The recommendation appears in the August 16, 2011 issue of Annals of Internal Medicine and is available on the USPSTF Web site at http://www.uspreventiveservicestaskforce.org/uspstf/uspsblad.htm.

The USPSTF is a national, independent panel of non-Federal medical experts that makes recommendations based on scientific evidence to primary care doctors and other health care providers about which clinical preventive services they should offer their patients.

full-contents ►Screening for Bladder Cancer: "Screening for Bladder Cancer in Adults

Release Date: August 2011

This topic page summarizes the U.S. Preventive Services Task Force (USPSTF) recommendations on screening for bladder cancer.

Summary of Recommendation / Supporting Documents
Summary of Recommendation

* The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for bladder cancer in asymptomatic adults.
Grade: I Statement.

Supporting Documents

Screening for Bladder Cancer in Adults, August 2011
▲ Recommendation Statement (PDF File, 199 KB; PDF Help) ►
http://www.uspreventiveservicestaskforce.org/uspstf11/bladdercancer/bladcanrs.pdf

▲ Evidence Review (PDF File, 62 KB; PDF Help) ►
http://www.uspreventiveservicestaskforce.org/uspstf11/bladdercancer/bladcanrev.pdf

▲ Evidence Synthesis (PDF File, 504 KB; PDF Help) ►
http://www.uspreventiveservicestaskforce.org/uspstf11/bladdercancer/bladcanes.pdf

▲ Clinical Summary (PDF File, 34 KB; PDF Help) ►
http://www.uspreventiveservicestaskforce.org/uspstf11/bladdercancer/bladcansum.pdf

Current as of August 2011

Internet Citation:

Screening for Bladder Cancer in Adults, Topic Page. August 2011. U.S. Preventive Services Task Force. http://www.uspreventiveservicestaskforce.org/uspstf/uspsblad.htm

- Enviado mediante la barra Google"